Our findings of a significant increase in blood SDF-1 alpha in LRRK2 mutation carriers and nominal decreases in CSF SDF-1 alpha in LRRK2 PD suggest a dysregulated gradient across the BBB, which may compromise its homeostasis and function in the CNS. Here, LRRK2 is linked to Parkinson disease.